Company Monitoring Page for Orexigen

latest headlines for company on cafepharma

Opportunity In The Weight Loss Drug Market
Seeking Alpha
Tue, 02/21/12 - 07:19 pm
Tags:
obesity, Vivus, Qnexa, Abbott Laboratories, Alkermes, GSK, JNJ, Roche, Orexigen
No Way? Obesity Drugs Have Side Effects
Motley Fool
Sat, 02/18/12 - 12:11 pm
Tags:
Vivus, obesity, Qnexa, Orexigen, Contrave, Arena Pharmaceuticals
3 Biotech Companies Down But Not Out
Seeking Alpha
Wed, 02/8/12 - 09:34 am
Tags:
Arena, Vivus, Orexigen, Biocryst, BioSante
Orexigen surges on FDA trial pact for troubled weight loss drug
Fierce Biotech
Tue, 02/7/12 - 10:50 am
Tags:
FDA, Orexigen, Contrave, obesity
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Minyanville
Fri, 01/13/12 - 10:26 am
Tags:
Vivus, Arena, Orexigen, obesity, lorcaserin, Qnexa, Contrave
A Diet Pill Comeback? Orexigen Revives Its Drug
Pharmalot
Wed, 09/21/11 - 09:26 am
Tags:
obesity, Orexigen, Contrave, FDA
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:52 pm
Tags:
Arena Pharmaceuticals, Orexigen, Vivus, Qnexa, weight loss, obesity
A Shrinking Obesity Market
Motley Fool
Sat, 09/17/11 - 02:51 pm
Tags:
weight loss, Vivus, Qnexa, Orexigen, Arena Pharmaceuticals
When to Buy Biotechnology Stocks?
Seeking Alpha
Mon, 08/15/11 - 10:30 am
Tags:
Alexion, Arena Pharmaceuticals, Dendreon, Human Genome Sciences, MannKind, Orexigen
Orexigen Revisited: Chances for Contrave Approval Seem Slim
Seeking Alpha
Wed, 08/10/11 - 05:29 pm
Tags:
Contrave, Orexigen, obesity
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 07/11/11 - 06:52 pm
Tags:
biotech, Gilead Sciences, Dendreon, PDL Biopharma, Cell Therapeutics, Amgen, Aeterna Zentaris, Xoma, Geron, Orexigen, Zalicus, Spectrum Pharmaceuticals, Ariad Pharmaceuticals, Biogen Idec, Momenta, StemCells
8 Potential Biotech Acquisition Candidates
Seeking Alpha
Mon, 06/20/11 - 09:30 am
Tags:
biotech, M&A, Arena Pharmaceuticals, Biomarin, Dendreon, Human Genome Sciences, Keryx, MannKind, Novartis, Orexigen, Vivus
3 Ways to Play Biotech With Options
Motley Fool
Tue, 06/14/11 - 08:05 pm
Tags:
Amarin, SIGA technologies, Acorda Therapeutics, Orexigen, Vivus
FDA Bullies Obesity Drugmakers
Motley Fool
Sat, 06/4/11 - 10:06 am
Tags:
Orexigen, Contrave, Vivus, Qnexa, Arena Pharmaceuticals, obesity, weight loss
Orexigen puts obesity drug development on hold
Yahoo/AP
Sat, 06/4/11 - 09:51 am
Tags:
Orexigen, obesity, weight loss, Contrave
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Yahoo/AP
Fri, 06/3/11 - 09:19 am
Tags:
FDA, Orexigen, obesity, Contrave
Orexigen shares jump on new hope for Contrave
Yahoo/AP
Wed, 06/1/11 - 06:39 pm
Tags:
Contrave, Orexigen, obesity
Arena's New Data Doesn't Change Obesity Pill Outlook
Investopedia
Mon, 05/30/11 - 06:39 pm
Tags:
obesity, Arena Pharmaceuticals, Human Genome Sciences, Dendreon, Orexigen, Vivus, Vanda
Arena, Orexigen and Vivus: An Update on Their Obesity Drugs
Seeking Alpha
Sat, 05/28/11 - 12:00 pm
Tags:
Arena Pharmaceuticals, Orexigen, Vivus, obesity, Qnexa, weight loss, Contrave
Orexigen Therapeutics posts smaller 1Q loss
Yahoo/AP
Mon, 05/9/11 - 04:59 pm
Tags:
Orexigen, earnings, Contrave

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.